European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC

Affiliations

¹ Division of Evidence-Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
² Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
³ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
⁴ Department of Dermatology, Paul Sabatier University, Toulouse, France.
⁵ Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
⁶ Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
⁷ St Johns Institute of Dermatology, Guys and St Thomas' Hospital Foundation Trust, London, UK.
⁸ Hospital Universitario de la Princesa, Madrid, Spain.
⁹ Radboud University medical center and Radboud University, Nijmegen, The Netherlands.
¹⁰ Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹¹ Cambridge, UK.
¹² Roma, Italy.
¹³ Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
¹⁴ Waterloo, Canada.
¹⁵ Dermatologikum Hamburg, Hamburg, Germany.
¹⁶ Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

Practice Guideline

A Nast et al. J Eur Acad Dermatol Venereol. 2017 Dec.

. 2017 Dec;31(12):1951-1963.

doi: 10.1111/jdv.14454. Epub 2017 Sep 11.

¹ Division of Evidence-Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
² Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
³ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
⁴ Department of Dermatology, Paul Sabatier University, Toulouse, France.
⁵ Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
⁶ Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
⁷ St Johns Institute of Dermatology, Guys and St Thomas' Hospital Foundation Trust, London, UK.
⁸ Hospital Universitario de la Princesa, Madrid, Spain.
⁹ Radboud University medical center and Radboud University, Nijmegen, The Netherlands.
¹⁰ Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹¹ Cambridge, UK.
¹² Roma, Italy.
¹³ Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
¹⁴ Waterloo, Canada.
¹⁵ Dermatologikum Hamburg, Hamburg, Germany.
¹⁶ Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

No abstract available

Publication types